US Stock MarketDetailed Quotes

VTGN VistaGen Therapeutics

Watchlist
  • 2.9700
  • -0.0600-1.98%
Close Jan 10 16:00 ET
  • 3.0700
  • +0.1000+3.37%
Post 20:01 ET
82.70MMarket Cap-4.01P/E (TTM)

VistaGen Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-75.86%-10.89M
-37.74%-10.87M
48.08%-25.81M
3.70%-7.2M
54.35%-4.53M
62.12%-6.19M
50.58%-7.89M
-9.85%-49.72M
52.06%-7.47M
17.54%-9.93M
Net income from continuing operations
-96.74%-12.96M
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
34.95%-6.35M
62.32%-6.59M
65.09%-6.9M
-24.05%-59.25M
26.73%-12.23M
7.35%-9.76M
Operating gains losses
----
----
-92.31%6K
----
----
----
----
--78K
--600
----
Depreciation and amortization
12.95%157K
8.63%151K
6.77%568K
6.24%146.5K
8.55%143.5K
4.83%139K
7.50%139K
-25.19%532K
3.37%137.9K
-58.16%132.2K
Other non cash items
----
----
----
----
----
----
----
--3.56M
----
----
Change In working capital
391.08%946K
15.80%-1.43M
-60.88%793K
262.40%1.65M
203.25%1.16M
-1,384.02%-325K
-162.31%-1.7M
205.69%2.03M
204.50%455.1K
55.77%-1.13M
-Change in prepaid assets
-79.07%104K
-365.38%-968K
-92.16%250K
-67.95%48.1K
-114.36%-87.1K
-62.65%497K
-118.90%-208K
265.77%3.19M
-21.33%150.1K
293.83%606.5K
-Change in payables and accrued expense
367.33%1.2M
62.49%-455K
155.89%522K
232.96%1.92M
118.38%268.8K
78.09%-450K
-160.44%-1.21M
-155.37%-934K
217.83%575.5K
3.38%-1.46M
-Change in other current assets
----
--190K
----
----
----
----
--0
----
----
----
-Change in other current liabilities
-63.33%-196K
-14.04%-130K
-14.32%-495K
-21.97%-136K
-14.16%-125K
-12.04%-120K
-8.67%-114K
36.04%-433K
-8.57%-111.5K
72.60%-109.5K
-Change in other working capital
109.92%25K
59.63%-65K
150.49%516K
-12.58%-179K
781.01%1.11M
-131.16%-252K
42.70%-161K
120.51%206K
-351.70%-159K
49.81%-162.7K
Cash from discontinued investing activities
Operating cash flow
-75.86%-10.89M
-37.74%-10.87M
48.08%-25.81M
3.70%-7.2M
54.35%-4.53M
62.12%-6.19M
50.58%-7.89M
-9.85%-49.72M
52.06%-7.47M
17.54%-9.93M
Investing cash flow
Cash flow from continuing investing activities
-7.79M
-5.47M
91.76%-61K
94.56%-28.7K
-158.40%-32.3K
0
0
-269.26%-740K
-527,900.00%-528K
-12,600.00%-12.5K
Net PPE purchase and sale
---61K
---42K
71.23%-61K
---28.7K
-158.40%-32.3K
--0
--0
-5.79%-212K
--0
-12,600.00%-12.5K
Net business purchase and sale
----
----
--0
----
----
----
----
---528K
----
----
Net investment purchase and sale
---7.73M
---5.43M
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
---7.79M
---5.47M
91.76%-61K
94.56%-28.7K
-158.40%-32.3K
--0
--0
-269.26%-740K
-527,900.00%-528K
-12,600.00%-12.5K
Financing cash flow
Cash flow from continuing financing activities
0
-89.94%88K
12,434.49%128.4M
57.78%-167.8K
30,852.65%93.52M
10,332.34%34.18M
16,009.09%875K
-109.93%-1.04M
-1,776.79%-397.4K
-114.35%-304.1K
Net issuance payments of debt
--0
--0
4.74%-985K
100.32%1K
--0
-154.70%-785K
-96.67%-201K
-34,366.67%-1.03M
-156,150.00%-312.5K
-31,010.00%-311.1K
Net common stock issuance
-100.25%-88K
-91.82%88K
184,927.14%129.38M
-99.17%-168.9K
--93.51M
115,469.64%34.96M
2,285.81%1.08M
-101.58%-70K
-129.99%-84.8K
--0
Proceeds from stock option exercised by employees
----
----
-87.30%8K
200.00%100
-44.29%3.9K
----
----
-98.96%63K
99.96%-100
-99.65%7K
Cash from discontinued financing activities
Financing cash flow
--0
-89.94%88K
12,434.49%128.4M
57.78%-167.8K
30,852.65%93.52M
10,332.34%34.18M
16,009.09%875K
-109.93%-1.04M
-1,776.79%-397.4K
-114.35%-304.1K
Net cash flow
Beginning cash position
969.61%102.92M
616.23%119.17M
-75.58%16.64M
405.48%126.56M
6.58%37.61M
-81.49%9.62M
-75.58%16.64M
-33.92%68.14M
-70.09%25.04M
-62.31%35.29M
Current changes in cash
-166.72%-18.67M
-131.58%-16.25M
299.10%102.53M
11.97%-7.39M
967.83%88.95M
267.59%27.99M
56.55%-7.02M
-47.25%-51.5M
46.04%-8.4M
-3.25%-10.25M
End cash Position
124.01%84.25M
969.61%102.92M
616.23%119.17M
616.23%119.17M
405.48%126.56M
6.58%37.61M
-81.49%9.62M
-75.58%16.64M
-75.58%16.64M
-70.09%25.04M
Free cash flow
-76.85%-10.95M
-38.27%-10.91M
48.18%-25.87M
3.32%-7.23M
54.08%-4.57M
62.18%-6.19M
51.12%-7.89M
-9.84%-49.93M
52.06%-7.47M
17.43%-9.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Sep 30, 2024 (Q1)Jun 30, 2024 (FY)Mar 31, 2024 (Q4)Mar 31, 2024 (Q3)Dec 31, 2023 (Q2)Sep 30, 2023 (Q1)Jun 30, 2023 (FY)Mar 31, 2023 (Q4)Mar 31, 2023 (Q3)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -75.86%-10.89M -37.74%-10.87M 48.08%-25.81M 3.70%-7.2M 54.35%-4.53M 62.12%-6.19M 50.58%-7.89M -9.85%-49.72M 52.06%-7.47M 17.54%-9.93M
Net income from continuing operations -96.74%-12.96M -55.48%-10.73M 50.44%-29.36M 22.13%-9.52M 34.95%-6.35M 62.32%-6.59M 65.09%-6.9M -24.05%-59.25M 26.73%-12.23M 7.35%-9.76M
Operating gains losses ---- ---- -92.31%6K ---- ---- ---- ---- --78K --600 ----
Depreciation and amortization 12.95%157K 8.63%151K 6.77%568K 6.24%146.5K 8.55%143.5K 4.83%139K 7.50%139K -25.19%532K 3.37%137.9K -58.16%132.2K
Other non cash items ---- ---- ---- ---- ---- ---- ---- --3.56M ---- ----
Change In working capital 391.08%946K 15.80%-1.43M -60.88%793K 262.40%1.65M 203.25%1.16M -1,384.02%-325K -162.31%-1.7M 205.69%2.03M 204.50%455.1K 55.77%-1.13M
-Change in prepaid assets -79.07%104K -365.38%-968K -92.16%250K -67.95%48.1K -114.36%-87.1K -62.65%497K -118.90%-208K 265.77%3.19M -21.33%150.1K 293.83%606.5K
-Change in payables and accrued expense 367.33%1.2M 62.49%-455K 155.89%522K 232.96%1.92M 118.38%268.8K 78.09%-450K -160.44%-1.21M -155.37%-934K 217.83%575.5K 3.38%-1.46M
-Change in other current assets ---- --190K ---- ---- ---- ---- --0 ---- ---- ----
-Change in other current liabilities -63.33%-196K -14.04%-130K -14.32%-495K -21.97%-136K -14.16%-125K -12.04%-120K -8.67%-114K 36.04%-433K -8.57%-111.5K 72.60%-109.5K
-Change in other working capital 109.92%25K 59.63%-65K 150.49%516K -12.58%-179K 781.01%1.11M -131.16%-252K 42.70%-161K 120.51%206K -351.70%-159K 49.81%-162.7K
Cash from discontinued investing activities
Operating cash flow -75.86%-10.89M -37.74%-10.87M 48.08%-25.81M 3.70%-7.2M 54.35%-4.53M 62.12%-6.19M 50.58%-7.89M -9.85%-49.72M 52.06%-7.47M 17.54%-9.93M
Investing cash flow
Cash flow from continuing investing activities -7.79M -5.47M 91.76%-61K 94.56%-28.7K -158.40%-32.3K 0 0 -269.26%-740K -527,900.00%-528K -12,600.00%-12.5K
Net PPE purchase and sale ---61K ---42K 71.23%-61K ---28.7K -158.40%-32.3K --0 --0 -5.79%-212K --0 -12,600.00%-12.5K
Net business purchase and sale ---- ---- --0 ---- ---- ---- ---- ---528K ---- ----
Net investment purchase and sale ---7.73M ---5.43M ---- ---- ---- --0 --0 ---- ---- ----
Cash from discontinued investing activities
Investing cash flow ---7.79M ---5.47M 91.76%-61K 94.56%-28.7K -158.40%-32.3K --0 --0 -269.26%-740K -527,900.00%-528K -12,600.00%-12.5K
Financing cash flow
Cash flow from continuing financing activities 0 -89.94%88K 12,434.49%128.4M 57.78%-167.8K 30,852.65%93.52M 10,332.34%34.18M 16,009.09%875K -109.93%-1.04M -1,776.79%-397.4K -114.35%-304.1K
Net issuance payments of debt --0 --0 4.74%-985K 100.32%1K --0 -154.70%-785K -96.67%-201K -34,366.67%-1.03M -156,150.00%-312.5K -31,010.00%-311.1K
Net common stock issuance -100.25%-88K -91.82%88K 184,927.14%129.38M -99.17%-168.9K --93.51M 115,469.64%34.96M 2,285.81%1.08M -101.58%-70K -129.99%-84.8K --0
Proceeds from stock option exercised by employees ---- ---- -87.30%8K 200.00%100 -44.29%3.9K ---- ---- -98.96%63K 99.96%-100 -99.65%7K
Cash from discontinued financing activities
Financing cash flow --0 -89.94%88K 12,434.49%128.4M 57.78%-167.8K 30,852.65%93.52M 10,332.34%34.18M 16,009.09%875K -109.93%-1.04M -1,776.79%-397.4K -114.35%-304.1K
Net cash flow
Beginning cash position 969.61%102.92M 616.23%119.17M -75.58%16.64M 405.48%126.56M 6.58%37.61M -81.49%9.62M -75.58%16.64M -33.92%68.14M -70.09%25.04M -62.31%35.29M
Current changes in cash -166.72%-18.67M -131.58%-16.25M 299.10%102.53M 11.97%-7.39M 967.83%88.95M 267.59%27.99M 56.55%-7.02M -47.25%-51.5M 46.04%-8.4M -3.25%-10.25M
End cash Position 124.01%84.25M 969.61%102.92M 616.23%119.17M 616.23%119.17M 405.48%126.56M 6.58%37.61M -81.49%9.62M -75.58%16.64M -75.58%16.64M -70.09%25.04M
Free cash flow -76.85%-10.95M -38.27%-10.91M 48.18%-25.87M 3.32%-7.23M 54.08%-4.57M 62.18%-6.19M 51.12%-7.89M -9.84%-49.93M 52.06%-7.47M 17.43%-9.95M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes -- --
Heat List
US
Overall
Symbol
Price
% Chg

No Data